In the phase 3 MAVERICK trial, people with small cell lung cancer who had regular brain MRIs instead of preventive whole-brain radiation kept their memory and thinking intact longer, with no clear ...

The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...

Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...

African American patients with newly diagnosed multiple myeloma were less likely than White patients to receive drugs that ...

Liver cancer treatment has changed a lot in five years, and how it changed tells you a lot about where it’s going. Most of ...

The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...

American Society for Radiation Oncology (ASTRO) published its first clinical practice guideline on radiation therapy for ...

Inspired by cancer's challenges, CURE® readers created art that celebrates life in the 2027 calendar. Whether you're facing uncertainty, finding strength, or celebrating a milestone, creating art ...

Educated Patient® In Person Education | CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

The hardest part of living with metastatic triple-negative breast cancer, a cancer that has spread to other parts of the body ...

Median progression-free survival reached 24.9 months with Tukysa plus Herceptin and Perjeta versus 16.3 months with placebo ...

For children with high-risk B-cell acute lymphoblastic leukemia (ALL), replacing part of their intensive chemotherapy with ...